首页> 外文期刊>Cutaneous and ocular toxicology >Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits
【24h】

Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits

机译:玻璃体内万古霉素和达托霉素在兔耐甲氧西林金黄色葡萄球菌(MRSA)眼内炎中的应用比较

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To compare bactericidal activities of daptomycin and vancomycin in an experimental rabbit model of methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis. Methods: The right eyes of 19 New Zealand rabbits weighing 2 to 2.5 kg were used. Each eye was inoculated with 1000 colony-forming units (cfu) of MRSA into the vitreous cavity. 24 h after the inoculation, the rabbits were randomly distributed into three groups: control group (n = 5) was given 0.1 ml of balanced saline solution, daptomycin group 2 (n = 7) was given 0.2 mg/0.1 ml daptomycin and vancomycin group 3 (n = 7) was given 1 mg/0.1 ml vancomycin intravitreally. Clinical examination scores were recorded and vitreous aspirates were obtained for microbiological analysis on days 2 and 3 after MRSA inoculation. Rabbits were sacrificed, and the eyes were enucleated for histopathological examination. Results: There was no difference between the daptomycin group, vancomycin group and control in terms of the clinical grading of endophthalmitis 24 h after the inoculation. In all treatment groups, mean number of cfu and histopathological scores were significantly lower compared to the control group. There was no difference between the daptomycin and vancomycin group in terms of the histopathological and clinical examination scores. Culture negativity achieved on day 3 was 71.4% and 57.1% in the daptomycin treatment group and the vancomycin treatment group, respectively. Conclusions: Although both daptomycin and vancomycin are effective in treatment of experimental MRSA endophthalmitis, daptomycin has superior bactericidal activity 72 h after inoculation.
机译:目的:比较达托霉素和万古霉素在耐甲氧西林的金黄色葡萄球菌(MRSA)眼内炎实验兔模型中的杀菌活性。方法:使用19只体重2至2.5kg的新西兰兔的右眼。每只眼睛接种了1000个MRSA菌落形成单位(cfu)进入玻璃体腔。接种后24小时,将兔随机分为三组:对照组(n = 5)给予0.1ml平衡盐溶液,达托霉素组2(n = 7)给予0.2mg / 0.1ml达托霉素和万古霉素组对3(n = 7)的患者玻璃体内给予1 mg / 0.1 ml万古霉素。记录临床检查成绩,并在接种MRSA后第2天和第3天获得玻璃体抽吸物以进行微生物分析。处死兔子,摘除眼睛以进行组织病理学检查。结果:达托霉素组,万古霉素组与对照组在接种后24小时眼内炎的临床分级方面无差异。与对照组相比,在所有治疗组中,cfu的平均数和组织病理学评分均显着降低。达托霉素和万古霉素组在组织病理学和临床检查评分方面无差异。在第3天,达托霉素治疗组和万古霉素治疗组的培养阴性率分别为71.4%和57.1%。结论:尽管达托霉素和万古霉素均能有效治疗实验性MRSA眼内炎,但达托霉素在接种后72小时具有优异的杀菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号